Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bjugstad KB, Goodman SI, Freed CR (2000) Age at symptom onset predicts severity of motorimpairment and clinical outcomeof glutaric acidemia type I. J Pediatr 137:681–686
Casey RE, Zaleski WA, Philp M, Mendelson IS, MacKenzie SL (1978) Biochemical and clinical studies of a new case of alpha-aminoadipic aciduria. J Inherit Metab Dis 1:129–135
Dancis J, Hutzler J, Cox RP (1979) Familial hyperlysinemia: enzyme studies, diagnostic methods, comments on terminology. Am J Hum Genet 31:290–299
Dancis J, Hutzler J, Ampola MG, Shih VE, Gelderen HH van, Kirby LT, Woody NC (1983) The prognosis of hyperlysinemia: an interim report. Am J Hum Genet 35:438–442
Elpeleg N, Korman SH (2001) Sustained oral lysine supplementation in ornithine deltaaminotransferase deficiency. J Inherit Metab Dis 24:423–424
Giordano C, De Santo NG, Pluvio M, Santinelli R, Stoppoloni G (1978) Lysine in treatment of hyperornithinemia. Nephron 22:97–106
Heinanen K, Nanto-Salonen K, Komu M, Erkintalo M, Heinonen OJ, Pulkki K, Valtonen M, Nikoskelainen E, Alanen A, Simell O (1999) Muscle creatine phosphate in gyrate atrophy of the choroid and retina with hyperornithinaemia-clues to pathogenesis. Eur J Clin Invest 29:426–431
Hoffmann GF, Trefz FK, Barth P, Böhles HJ, Biggemann B, Bremer HJ, Christensen E, Frosch M, Hanefeld F, Hunneman DH, Jacobi H, Kurlemann G, Lawrenz-Wolf B, Rating D, Roe CR, Schutgens RB, Ullrich K, Weisser J, Wendel U, Lehnert W (1991) Glutaryl-CoA dehydrogease deficiency: a distinct encephalopathy. Pediatrics 88:1194–1203
Hoffmann GF, Athanassopoulos S, Burlina AB; Duran M, deKlerck JBC, Lehnert W, Leonard JV, Monavari AA; Müller E, Muntau AC, Naughten ER, Plecko-Starting B, Superti-Furga A, Zschocke J, Christensen E (1996) Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics 27:115–123
Kaiser Kupfer MI, Caruso RC, Valle D (1991) Gyrate atrophy of the choroid and retina. Long-term reduction of ornithine slows retinal degeneration. Arch Ophthalmol 109:1539–1548
Kölker S, Raemekers VT, Zschocke J, Hoffmann GF (2001) Acute encephalopathy despite early therapy in a patient with homozygosity for E365K in the glutaryl-CoA dehydrogenase gene. J Pediatr 138:277–279
Monavari AA, Naughten ER (2000) Prevention of cerebral palsy in glutaric aciduria type I by dietary management. Arch Dis Child 82:67–70
Peltola K, Heinonen OJ, Nanto-Salonen K, Pulkki K, Simell O (2000) Oral lysine feeding in gyrate atrophy with hyperornithinaemia-a pilot study. J Inherit Metab Dis 23:305–307
Schulze A, Lindner M, Kohlmueller D, Olgemoeller K, Mayatepek E, Hoffmann GF (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111:1399–1406
Strauss KA, Puffenberger EG, Robinson DL, Morton DH (2003) Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet 121:38–52
Valle D, Walser M, Brusilow SW, Kaiser-Kupfer M (1980) Gyrate atrophy of the choroid and retina: amino acid metabolism and correction of hyperornithinemia with an arginine-deficient diet. J Clin Invest 65:371–378
Valle D, Walser M, Brusilow S, Kaiser-Kupfer MI, Takki K (1981) Gyrate atrophy of the choroid and retina. Biochemical considerations and experience with an argininerestricted diet. Ophthalmology 88:325–330
Weleber RG, Kennaway NG (1981) Clinical trial of vitamin B6 for gyrate atrophy of the choroid and retina. Ophthalmology 88:316–324
Weleber RG, Kennaway NG, Buist NR (1978) Vitamin B6 in management of gyrate atrophy of choroid and retina. Lancet 2:1213
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hoffmann, G.F., Schulze, A. (2006). Disorders of Ornithine, Lysine, and Tryptophan. In: Blau, N., Leonard, J., Hoffmann, G.F., Clarke, J.T.R. (eds) Physician’s Guide to the Treatment and Follow-Up of Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28962-3_14
Download citation
DOI: https://doi.org/10.1007/3-540-28962-3_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22954-4
Online ISBN: 978-3-540-28962-3
eBook Packages: MedicineMedicine (R0)